Print full article

New feline core vaccine available from BIVI

Ultra Hybrid FVRCP offers a 0.5 mL dose and is packaged with a “chain of custody” label

Suggested Veterinary Products

Boehringer Ingelheim Vetmedica Inc. has released a reduced-volume core vaccine for cats.

The nonadjuvanted Ultra Hybrid FVRCP is administered in a 0.5 mL subcutaneous dose to protect against feline herpesvirus, calicivirus infection and distemper in cats at least 8 weeks old.

The name “Hybrid” accurately describes the vaccine, said Arne Zislin, VMD, veterinary technical manager at BIVI.

“Hybrid refers to the combination of inactivated dual-strain calicivirus with a modified live feline panleukopenia and herpesvirus in one nonadjuvanted, reduced-volume vaccine,” Dr. Zislin said.

Ultra Hybrid FVRCP is the first BIVI vaccine to feature a three-part “chain of custody” label.

“The label provides the ability to track what vaccines the pet has received in the clinic and at home,” BIVI stated.

A survey conducted by the St. Joseph, Mo., company in February found that 7-in-10 veterinarians believe that providing a “happy vaccine experience” for patients is very important. The new vaccine uses PureFil Technology, which BIVI stated decreases “vaccine reactions by reducing extraneous proteins and cellular debris.”

Leave a Comment



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.